$ALT
Altimmune Inc

2021 Q3 Form 10-Q Financial Statement

#000155837021011132 Filed on August 10, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q2 2020 Q2
Revenue $157.6K $137.0K $721.6K
YoY Change -94.64% -81.02% -55.62%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.156M $3.659M $2.550M
YoY Change -1.52% 43.48% 14.35%
% of Gross Profit
Research & Development $29.21M $13.27M $16.59M
YoY Change 71.38% -20.02% 463.45%
% of Gross Profit
Depreciation & Amortization $100.0K $68.45K $60.66K
YoY Change 0.0% 12.83% -24.17%
% of Gross Profit
Operating Expenses $33.36M $25.00M $19.14M
YoY Change 56.91% 30.62% 549.88%
Operating Profit -$33.20M -$24.86M -$18.42M
YoY Change 81.2% 35.0%
Interest Expense $32.87K $22.00K $3.308K
YoY Change 1344.66% 565.05% 342.25%
% of Operating Profit
Other Income/Expense, Net -$306.6K $37.00K $72.27K
YoY Change -525.39% -48.8% -55.93%
Pretax Income -$33.51M -$24.83M -$18.35M
YoY Change 83.6% 35.33% 441.67%
Income Tax $0.00 $0.00 -$1.579M
% Of Pretax Income
Net Earnings -$33.51M -$24.83M -$16.77M
YoY Change 88.58% 48.07% 395.05%
Net Earnings / Revenue -21268.66% -18121.9% -2323.46%
Basic Earnings Per Share -$0.81 -$0.60
Diluted Earnings Per Share -$0.81 -$0.60 -$937.4K
COMMON SHARES
Basic Shares Outstanding 39.71M 41.36M
Diluted Shares Outstanding 41.37M 41.36M

Balance Sheet

Concept 2021 Q3 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $199.9M $217.8M $80.20M
YoY Change -3.34% 171.6% 92.33%
Cash & Equivalents $174.9M $174.1M $64.78M
Short-Term Investments $25.02M $43.72M $15.50M
Other Short-Term Assets $7.329M $9.447M $1.000M
YoY Change 463.73% 844.72% 42.86%
Inventory
Prepaid Expenses
Receivables $1.574M $4.463M $1.200M
Other Receivables $9.476M $6.888M $5.500M
Total Short-Term Assets $218.3M $238.6M $88.00M
YoY Change 0.06% 171.16% 90.87%
LONG-TERM ASSETS
Property, Plant & Equipment $4.718M $4.751M $1.700M
YoY Change 352.83% 179.47% 39.1%
Goodwill
YoY Change
Intangibles $12.99M $12.96M
YoY Change 1.55%
Long-Term Investments
YoY Change
Other Assets $931.9K $928.8K $100.0K
YoY Change 968.76% 828.84% -35.94%
Total Long-Term Assets $18.64M $18.64M $14.50M
YoY Change 25.43% 28.52% -8.64%
TOTAL ASSETS
Total Short-Term Assets $218.3M $238.6M $88.00M
Total Long-Term Assets $18.64M $18.64M $14.50M
Total Assets $236.9M $257.3M $102.5M
YoY Change 1.68% 150.99% 65.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.083K $1.421M $200.0K
YoY Change -99.3% 610.6% -33.33%
Accrued Expenses $19.12M $7.675M $4.090M
YoY Change 252.86% 87.65% 34.24%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $600.0K
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $19.13M $9.096M $4.900M
YoY Change 203.91% 85.63% 40.79%
LONG-TERM LIABILITIES
Long-Term Debt $1.566M $1.617M $1.715M
YoY Change -18.7% -5.71% 471.67%
Other Long-Term Liabilities $85.49K $90.44K $110.2K
YoY Change -25.84% -17.97% -94.49%
Total Long-Term Liabilities $1.651M $1.708M $1.825M
YoY Change -19.1% -6.45% -20.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.13M $9.096M $4.900M
Total Long-Term Liabilities $1.651M $1.708M $1.825M
Total Liabilities $27.64M $15.98M $23.00M
YoY Change -16.96% -30.51% 299.93%
SHAREHOLDERS EQUITY
Retained Earnings -$269.3M -$235.8M
YoY Change 53.18%
Common Stock $3.959K $3.956K
YoY Change 20.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $209.3M $241.3M $79.52M
YoY Change
Total Liabilities & Shareholders Equity $236.9M $257.3M $102.5M
YoY Change 1.68% 150.99% 65.39%

Cashflow Statement

Concept 2021 Q3 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$33.51M -$24.83M -$16.77M
YoY Change 88.58% 48.07% 395.05%
Depreciation, Depletion And Amortization $100.0K $68.45K $60.66K
YoY Change 0.0% 12.83% -24.17%
Cash From Operating Activities -$17.78M -$18.93M -$7.170M
YoY Change 87.11% 163.96% 134.31%
INVESTING ACTIVITIES
Capital Expenditures -$114.1K -$7.776M -$80.00K
YoY Change 42.61% 9619.68% 300.0%
Acquisitions
YoY Change
Other Investing Activities $18.53M $32.85M $6.180M
YoY Change -138.75% 431.52%
Cash From Investing Activities $18.41M $25.07M $6.100M
YoY Change -138.45% 311.02% -30600.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 124.4K 18.02M 54.54M
YoY Change -99.91% -66.96% -34187.5%
NET CHANGE
Cash From Operating Activities -17.78M -18.93M -7.170M
Cash From Investing Activities 18.41M 25.07M 6.100M
Cash From Financing Activities 124.4K 18.02M 54.54M
Net Change In Cash 761.2K 24.16M 53.47M
YoY Change -99.03% -54.81% -1750.31%
FREE CASH FLOW
Cash From Operating Activities -$17.78M -$18.93M -$7.170M
Capital Expenditures -$114.1K -$7.776M -$80.00K
Free Cash Flow -$17.66M -$11.15M -$7.090M
YoY Change 87.49% 57.26% 133.22%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001326190
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2021Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2020Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2021Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2020Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39693524
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37142946
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P12Y2M18D
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-32587
dei Entity Registrant Name
EntityRegistrantName
ALTIMMUNE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-2726770
dei Entity Address Address Line1
EntityAddressAddressLine1
910 Clopper Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 201S
dei Entity Address City Or Town
EntityAddressCityOrTown
Gaithersburg
dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20878
dei City Area Code
CityAreaCode
240
dei Local Phone Number
LocalPhoneNumber
654-1450
dei Security12b Title
Security12bTitle
Common stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
ALT
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
39705884
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
174102382
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
115917807
CY2021Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
34174
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
34174
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
174136556
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
115951981
CY2021Q2 us-gaap Short Term Investments
ShortTermInvestments
43723840
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
100005558
CY2021Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
4463442
CY2020Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
4610202
CY2021Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
6887981
CY2020Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
7762793
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9413070
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1926675
CY2021Q2 us-gaap Assets Current
AssetsCurrent
238624889
CY2020Q4 us-gaap Assets Current
AssetsCurrent
230257209
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4751010
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1056920
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12956112
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12823846
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
928839
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
977238
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-186420599
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5038240
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5044517
CY2021Q2 us-gaap Assets
Assets
257260850
CY2020Q4 us-gaap Assets
Assets
245115213
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1421192
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
612293
CY2021Q2 alt Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
7674536
CY2020Q4 alt Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
11408154
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
9095728
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12020447
CY2021Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
5270000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
5390000
CY2021Q2 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
1617150
CY2020Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
1828443
CY2021Q2 us-gaap Liabilities
Liabilities
15982878
CY2020Q4 us-gaap Liabilities
Liabilities
19238890
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39693524
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37142946
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
3956
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
3697
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
482083670
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
417337742
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-235771414
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
241277972
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
225876323
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
257260850
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
245115213
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
137623
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
721636
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
975139
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2934330
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13272412
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16594250
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25150312
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23781781
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3658653
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2545356
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7480073
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4877273
CY2021Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
8070000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
8070000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
25001065
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
19139606
CY2020Q2 us-gaap Interest Expense
InterestExpense
3308
us-gaap Operating Expenses
OperatingExpenses
40700385
us-gaap Operating Expenses
OperatingExpenses
28659054
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-24863442
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-18417970
us-gaap Operating Income Loss
OperatingIncomeLoss
-39725246
us-gaap Operating Income Loss
OperatingIncomeLoss
-25724724
CY2021Q2 us-gaap Interest Expense
InterestExpense
22226
us-gaap Interest Expense
InterestExpense
33897
us-gaap Interest Expense
InterestExpense
5193
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
32863
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
81458
us-gaap Investment Income Interest
InvestmentIncomeInterest
75362
us-gaap Investment Income Interest
InvestmentIncomeInterest
233027
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
26098
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5878
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7034
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
19664
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
36735
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
72272
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
34431
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
247498
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24826707
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18345698
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-39690815
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25477226
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1578782
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4824661
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-24826707
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-16766916
us-gaap Net Income Loss
NetIncomeLoss
-39690815
us-gaap Net Income Loss
NetIncomeLoss
-20652565
CY2021Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1141
CY2020Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
20888
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
6277
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-11547
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-24825566
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-16746028
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-39684538
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-20664112
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.60
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.94
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.99
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.25
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
41356643
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17886853
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40142561
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
16498719
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
225876323
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1218351
CY2021Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-92506
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
106001
CY2021Q1 alt Retirement Of Common Sock In Exchange For Common Stock Warrant
RetirementOfCommonSockInExchangeForCommonStockWarrant
-17200000
CY2021Q1 alt Issuance Of Common Stock Warrant In Exchange For Retirement Of Common Stock
IssuanceOfCommonStockWarrantInExchangeForRetirementOfCommonStock
-17200000
CY2021Q1 alt Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
10000
CY2021Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
5136
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-14864108
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
246437428
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1484829
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
94429
CY2021Q2 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-91121
CY2021Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1141
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-24826707
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
241277972
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
45520146
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
214921
CY2020Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-17079
CY2020Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
56739
CY2020Q1 alt Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
39974
CY2020Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-32435
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-3885649
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
41896617
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
330510
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
36175
CY2020Q2 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-46389
CY2020Q2 alt Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
31270163
CY2020Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
20888
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-16766916
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
79521777
us-gaap Profit Loss
ProfitLoss
-39690815
us-gaap Profit Loss
ProfitLoss
-20652565
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-120000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
13640000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
8070000
us-gaap Share Based Compensation
ShareBasedCompensation
2703180
us-gaap Share Based Compensation
ShareBasedCompensation
545431
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
149388
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
146045
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-10108
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
18851
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
93672
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
160920
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7155593
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
343337
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
808899
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
176985
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-4052095
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
26761
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-874812
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
4877851
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-38495788
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11518302
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
63712000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
24900000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
7424005
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
12118563
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11900198
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
40601
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
145546
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
79336
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
44242251
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
12661500
alt Payments Of Deferred Offering Costs
PaymentsOfDeferredOfferingCosts
118522
alt Payments Of Deferred Offering Costs
PaymentsOfDeferredOfferingCosts
179743
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
31310137
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
52356204
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
22780729
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
632000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
106001
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
56739
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
94429
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
36175
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
52438112
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
54636037
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
58184575
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
55779235
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
115951981
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8996860
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
174136556
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
64776095
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
404879
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of these financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The extent to which the COVID-19 pandemic may directly or indirectly impact the Company’s business, financial condition, and results of operations is highly uncertain and subject to change. The Company considered the potential impact of the COVID-19 pandemic on the Company’s estimates and assumptions and determined that there was not a material impact to the Company’s unaudited consolidated financial statements as of and for the three and six months ended June 30, 2021. However, actual results could differ from those estimates and there may be changes to the Company’s estimates in future periods.</p>
CY2021Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
43721917
CY2021Q2 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
1923
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
43723840
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
100009912
CY2020Q4 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
-4354
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
100005558
CY2021Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q2 alt Assets Or Liabilities Measured At Fair Value On Non Recurring Basis
AssetsOrLiabilitiesMeasuredAtFairValueOnNonRecurringBasis
0
CY2020Q4 alt Assets Or Liabilities Measured At Fair Value On Non Recurring Basis
AssetsOrLiabilitiesMeasuredAtFairValueOnNonRecurringBasis
0
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
8100000
CY2021Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
8100000
CY2021Q2 us-gaap Property Plant And Equipment Fair Value Disclosure
PropertyPlantAndEquipmentFairValueDisclosure
3300000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
8100000
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
778188
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
537145
CY2021Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
13734300
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
778188
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6579568
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2655731
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1828558
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1598811
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4751010
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1056920
CY2021Q2 us-gaap Depreciation
Depreciation
68450
CY2020Q2 us-gaap Depreciation
Depreciation
60664
us-gaap Depreciation
Depreciation
136108
us-gaap Depreciation
Depreciation
120169
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1315333
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12956112
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1169787
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
764908
CY2020Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
13588754
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
764908
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12823846
alt Non Cancellable Lease Maturity Period
NonCancellableLeaseMaturityPeriod
2022-12
CY2021Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
123734
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
253872
CY2020Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
86295
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
173894
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
118843
us-gaap Operating Lease Payments
OperatingLeasePayments
236197
CY2020Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
96770
us-gaap Operating Lease Payments
OperatingLeasePayments
192484
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1651217
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1824840
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
827273
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
903825
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y9M18D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y3M18D
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.073
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.073
CY2021Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
489836
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1350194
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1661708
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2351599
CY2021Q2 us-gaap Interest Payable Current
InterestPayableCurrent
16456
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
13016
CY2021Q2 alt Accrued Research And Development
AccruedResearchAndDevelopment
5074045
CY2020Q4 alt Accrued Research And Development
AccruedResearchAndDevelopment
7316876
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
374502
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
356716
CY2021Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
57989
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
19753
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7674536
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11408154
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
5390000
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
2750000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-120000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
13640000
CY2021Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
5270000
CY2020Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
16390000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1276715
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1468124
CY2021Q2 alt Economic Conditional Incentive Grants
EconomicConditionalIncentiveGrants
250000
CY2020Q4 alt Economic Conditional Incentive Grants
EconomicConditionalIncentiveGrants
250000
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
90435
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
110319
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1617150
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1828443
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1777611
us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
1000000
alt Number Of Warrants Exercised For Conversion Of Securities
NumberOfWarrantsExercisedForConversionOfSecurities
1420
CY2021Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2776191
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2492949
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.31
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y11M15D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
17162458
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
863736
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.36
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y9M14D
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
8464765
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1629213
alt Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedOutstandingWeightedAverageExercisePrice
9.87
alt Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedOutstandingWeightedAverageRemainingContractualTerm
P6Y18D
CY2021Q2 alt Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOutstandingIntrinsicValue
8697693
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1484829
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
330510
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2703180
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
545431
CY2020Q2 us-gaap Income Tax Examination Liability Refund Adjustment From Settlement With Taxing Authority
IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority
4800000

Files In Submission

Name View Source Status
0001558370-21-011132-index-headers.html Edgar Link pending
0001558370-21-011132-index.html Edgar Link pending
0001558370-21-011132.txt Edgar Link pending
0001558370-21-011132-xbrl.zip Edgar Link pending
alt-20210630.xsd Edgar Link pending
alt-20210630x10q.htm Edgar Link pending
alt-20210630x10q002.jpg Edgar Link pending
alt-20210630x10q_htm.xml Edgar Link completed
alt-20210630xex10d1.htm Edgar Link pending
alt-20210630xex10d1001.jpg Edgar Link pending
alt-20210630xex10d1002.jpg Edgar Link pending
alt-20210630xex10d1003.jpg Edgar Link pending
alt-20210630xex10d1004.jpg Edgar Link pending
alt-20210630xex10d1005.jpg Edgar Link pending
alt-20210630xex10d1006.jpg Edgar Link pending
alt-20210630xex10d1007.jpg Edgar Link pending
alt-20210630xex10d1008.jpg Edgar Link pending
alt-20210630xex10d1009.jpg Edgar Link pending
alt-20210630xex10d1010.jpg Edgar Link pending
alt-20210630xex10d1011.jpg Edgar Link pending
alt-20210630xex10d1013.jpg Edgar Link pending
alt-20210630xex10d1014.jpg Edgar Link pending
alt-20210630xex10d1015.jpg Edgar Link pending
alt-20210630xex10d1016.jpg Edgar Link pending
alt-20210630xex10d1018.jpg Edgar Link pending
alt-20210630xex10d1044.jpg Edgar Link pending
alt-20210630xex10d1045.jpg Edgar Link pending
alt-20210630xex10d1048.jpg Edgar Link pending
alt-20210630xex10d1049.jpg Edgar Link pending
alt-20210630xex10d1052.jpg Edgar Link pending
alt-20210630xex10d1054.jpg Edgar Link pending
alt-20210630xex10d1056.jpg Edgar Link pending
alt-20210630xex10d1057.jpg Edgar Link pending
alt-20210630xex10d1058.jpg Edgar Link pending
alt-20210630xex10d1059.jpg Edgar Link pending
alt-20210630xex10d1060.jpg Edgar Link pending
alt-20210630xex31d1.htm Edgar Link pending
alt-20210630xex31d2.htm Edgar Link pending
alt-20210630xex32d1.htm Edgar Link pending
alt-20210630xex32d2.htm Edgar Link pending
alt-20210630_cal.xml Edgar Link unprocessable
alt-20210630_def.xml Edgar Link unprocessable
alt-20210630_lab.xml Edgar Link unprocessable
alt-20210630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending